The epigenetic effect of glucosamine and a nuclear factor-kappa B (NF-kB) inhibitor on primary human chondrocytes--implications for osteoarthritis.
about
Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis?Glucosamine for osteoarthritis: biological effects, clinical efficacy, and safety on glucose metabolismCrystalline glucosamine sulfate in the management of knee osteoarthritis: efficacy, safety, and pharmacokinetic propertiesSignificance of epigenetic landscape in cartilage regeneration from the cartilage development and pathology perspective.Pentosan polysulfate inhibits IL-1β-induced iNOS, c-Jun and HIF-1α upregulation in canine articular chondrocytes.Oxidative stress in the pathology and treatment of systemic lupus erythematosusThe effects of amphiregulin induced MMP-13 production in human osteoarthritis synovial fibroblast.Role of glucosamine in the treatment for osteoarthritisAssociation of reduced type IX collagen gene expression in human osteoarthritic chondrocytes with epigenetic silencing by DNA hypermethylationEpigenetic regulation during fetal femur development: DNA methylation matters.Physiological effects of oral glucosamine on joint health: current status and consensus on future research prioritiesChondroitin and glucosamine in the management of osteoarthritis: an update.Epigenomic and microRNA-mediated regulation in cartilage development, homeostasis, and osteoarthritisEpigenetic regulation of interleukin-8, an inflammatory chemokine, in osteoarthritis.Epigenetics and the transition from acute to chronic pain.Glucosamine activates autophagy in vitro and in vivo.MicroRNA-9 regulates the development of knee osteoarthritis through the NF-kappaB1 pathway in chondrocytesInflammation and epigenetic regulation in osteoarthritis.Suppressors of cytokine signalling (SOCS) are reduced in osteoarthritis.Inflammation in osteoarthritis.Loss of methylation in CpG sites in the NF-κB enhancer elements of inducible nitric oxide synthase is responsible for gene induction in human articular chondrocytes.Modulation of ten-eleven translocation 1 (TET1), Isocitrate Dehydrogenase (IDH) expression, α-Ketoglutarate (α-KG), and DNA hydroxymethylation levels by interleukin-1β in primary human chondrocytes.Epigenetic modifications of interleukin-6 in synovial fibroblasts from osteoarthritis patientsThe osteoarthritic niche and modulation of skeletal stem cell function for regenerative medicine.Impact of inflammation on the osteoarthritic niche: implications for regenerative medicine.Epigenetics in osteoarthritis and its implication for future therapeutics.Experimental pharmacology of glucosamine sulfate.ELF3 modulates type II collagen gene (COL2A1) transcription in chondrocytes by inhibiting SOX9-CBP/p300-driven histone acetyltransferase activity.Matrilin-3 induction of IL-1 receptor antagonist is required for up-regulating collagen II and aggrecan and down-regulating ADAMTS-5 gene expression.Sirtuin 1 regulates matrix metalloproteinase-13 expression induced by Porphyromonas endodontalis lipopolysaccharide via targeting nuclear factor-κB in osteoblasts.Glucosamine and chondroitin for the treatment of osteoarthritis.Evaluation of intra-articular injection of autologous platelet lysate (PL) in horses with osteoarthritis of the distal interphalangeal joint.DNMT3a methylation in neuropathic pain.Genome-wide DNA methylation analysis of articular chondrocytes reveals a cluster of osteoarthritic patients.CX3CL1 promotes MMP-3 production via the CX3CR1, c-Raf, MEK, ERK, and NF-κB signaling pathway in osteoarthritis synovial fibroblasts.Parthenolide inhibits pro-inflammatory cytokine production and exhibits protective effects on progression of collagen-induced arthritis in a rat model.Effects of a proteasome inhibitor on the NF-κB signalling pathway in experimental osteoarthritis.Combined bioinformatics analysis reveals gene expression and DNA methylation patterns in osteoarthritis.DNA Methylation in Osteoarthritis: Current Status and Therapeutic Implications.TLR10 and NFKBIA contributed to the risk of hip osteoarthritis: systematic evaluation based on Han Chinese population.
P2860
Q21195259-C1FEB1F4-B78A-444D-A443-A5CC104CC4A3Q21284705-FEB0BE7E-8B2E-463C-8EB9-DF410AA9EEAAQ24630640-DE370231-0D1E-4C44-AD9C-E0CDC8C70C23Q33637249-0E573A0E-325D-4B27-9141-92C681DE7573Q33638183-C3CD841E-9883-49FD-A834-79E13341243BQ33715508-2B05E3A8-E894-4D93-8B40-AD02B0BBDDB2Q34039540-F8EE6AD6-E0C3-41B7-9CE4-02539ECD756EQ34264613-6A7A293A-A8B2-4769-B146-59A49D4EB2A9Q34416053-F399FC83-6439-4A3D-A1C8-BEA39BD745A9Q34575845-93627A21-0813-4398-A879-7497028B139CQ34636799-07AEE2F2-63BE-49AC-894B-001F9218DED7Q34655436-3EBE866B-7310-4A76-8F82-EA5B8D0B54E2Q35764680-CD113EBB-1D19-4BF1-94FA-48EED3DD4342Q36263516-A25C3C78-78EF-47EC-9F5C-220E7502177DQ36409626-CB87BD8D-77D6-43BC-9DC3-EED00ABFE27BQ37168084-E8C91BC7-D15D-45E1-8B68-AD2494618445Q37256802-CAEE213D-A74D-494C-8E69-73A779AA1649Q37606976-35EE9E41-5D33-4A0D-ACB3-F4E1609CE992Q37608884-1054B714-CFB8-4632-A443-6DD277D6CA2CQ37608903-80CE4606-7D2C-4116-8882-26CC03C98AFCQ37609036-A06AAFCC-65E7-4FFB-AAD8-5F3D93A9E608Q37622608-C0AB23EB-B9BB-4B42-95E3-BF59B7B19B81Q37681712-9ED00F07-23E9-4164-8339-9C2D6D55D1FEQ38001412-84F97A04-BBCA-473C-8E07-8C116B73BD50Q38027919-17C65DA4-0C8D-45D3-897E-1C09A5926370Q38081554-D20F3846-8AD5-46C5-B0E9-97B2FA58879AQ38684643-4515D72D-11D2-453B-8FDB-173B2D617FABQ38764119-1B22F759-1F56-4F5B-BFC7-3A9108BC71B7Q39281187-8DA949AD-90F8-4B2D-8FFD-3DCE389F4B4CQ42220876-540B0656-A908-40F1-829A-2A145B86150AQ42330053-A9C961AD-5564-4154-AD74-660F0C81AA40Q42488352-28966B7D-29DC-453E-AC1E-17FA1D9EC0D6Q42731697-8FF336AA-6063-4BF1-B591-9B0454AA9059Q45750089-7E34E58D-3B9D-4CA4-BA4A-2D2295F9C2BCQ47131296-5D00A2BC-8D75-4559-9C40-D56F28367924Q50220083-9DB3E7F9-8F61-458F-8227-86CCA6CC4424Q50858452-2B8B8FEC-8D43-4A69-8579-40389AB3FD46Q52586734-B848D394-392F-46F8-94F3-60A5AC25849FQ54974118-3AC58B71-B47D-4450-86AE-446A3822727CQ55604928-40FF5E1D-D255-484C-9517-B7D2B6199136
P2860
The epigenetic effect of glucosamine and a nuclear factor-kappa B (NF-kB) inhibitor on primary human chondrocytes--implications for osteoarthritis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The epigenetic effect of gluco ...... plications for osteoarthritis.
@ast
The epigenetic effect of gluco ...... plications for osteoarthritis.
@en
The epigenetic effect of glucosamine and a nuclear factor-kappa B
@nl
type
label
The epigenetic effect of gluco ...... plications for osteoarthritis.
@ast
The epigenetic effect of gluco ...... plications for osteoarthritis.
@en
The epigenetic effect of glucosamine and a nuclear factor-kappa B
@nl
prefLabel
The epigenetic effect of gluco ...... plications for osteoarthritis.
@ast
The epigenetic effect of gluco ...... plications for osteoarthritis.
@en
The epigenetic effect of glucosamine and a nuclear factor-kappa B
@nl
P2093
P2860
P1476
The epigenetic effect of gluco ...... plications for osteoarthritis.
@en
P2093
Dominic Pitt
Helmtrud I Roach
Kei Imagawa
Ko Hashimoto
M C de Andrés
Mary B Goldring
P2860
P304
P356
10.1016/J.BBRC.2011.01.007
P407
P577
2011-01-08T00:00:00Z